ID

40243

Description

Study ID: 110635 Clinical Study ID: 110635 Study Title: A double-blind, randomized, placebo controlled, parallel group, multi-center, phase III trial of ofatumumab investigating clinical efficacy in adult patients with active rheumatoid arthritis who had an inadequate response to methotrexate therapy (FINAL ANALYSIS: follow-up period and cumulative safety data across the whole study) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00611455 Sponsor: GlaxoSmithKline Phase: Phase 3 Study Recruitment Status: Completed Generic Name: ofatumumab, Placebo Study Indication: Arthritis, Rheumatoid

Mots-clés

Versions (1)
  1. 24/03/2020 24/03/2020 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

24 mars 2020

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Efficacy of ofatumumab in adult patients with active rheumatoid arthritis with inadequate response to methotrexate NCT00611455

Anglais

End of Double Blind - Administrative; Subject Continuation; Phase Conclusion

1 Formulaires  
Administrative
Description

Administrative

Alias
UMLS CUI-1
C1320722
Date of Visit/ Assessment
Description

Date of Visit/ Assessment

Type de données

date

Alias
UMLS CUI [1,1]
C1320303
UMLS CUI [1,2]
C2985720
Subject Continuation
Description

Subject Continuation

Alias
UMLS CUI-1
C0805733
Is the subject continuing in the study?
Description

If the subject is an early withdrawal, tick No for subject continuation If yes, complete the Phase conclusion section and proceed with the Open-label Period If No, complete the Phase conclusion section and proceed with the Follow-up Period

Type de données

boolean

Alias
UMLS CUI [1]
C0805733
Phase Conclusion
Description

Phase Conclusion

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0205390
Did the subject fail to complete this phase of the study?
Description

If yes, complete date and primary reason for withdrawal

Type de données

boolean

Alias
UMLS CUI [1,1]
C0805732
UMLS CUI [1,2]
C0231175
UMLS CUI [2,1]
C0205390
UMLS CUI [2,2]
C2603343
Date subject failed to complete
Description

Date subject failed to complete

Type de données

date

Alias
UMLS CUI [1,1]
C0805732
UMLS CUI [1,2]
C0231175
UMLS CUI [2,1]
C0205390
UMLS CUI [2,2]
C2603343
UMLS CUI [3]
C0011008
Primary reason for withdrawal
Description

Primary reason for withdrawal

Type de données

integer

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0392360
Specify Investigator discretion
Description

Specify Investigator discretion

Type de données

text

Alias
UMLS CUI [1,1]
C2348235
UMLS CUI [1,2]
C0008961
UMLS CUI [1,3]
C0022423
Specify withdrew consent
Description

Specify withdrew consent

Type de données

text

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C2348235
Retour au début de la page

Similar models

End of Double Blind - Administrative; Subject Continuation; Phase Conclusion

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Administrative
C1320722 (UMLS CUI-1)
Date of Visit/ Assessment
Item
Date of Visit/ Assessment
date
C1320303 (UMLS CUI [1,1])
C2985720 (UMLS CUI [1,2])
Item Group
Subject Continuation
C0805733 (UMLS CUI-1)
Is the subject continuing in the study?
Item
Is the subject continuing in the study?
boolean
C0805733 (UMLS CUI [1])
Item Group
Phase Conclusion
C1707478 (UMLS CUI-1)
C0205390 (UMLS CUI-2)
Did the subject fail to complete this phase of the study?
Item
Did the subject fail to complete this phase of the study?
boolean
C0805732 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
C0205390 (UMLS CUI [2,1])
C2603343 (UMLS CUI [2,2])
Date subject failed to complete
Item
Date subject failed to complete
date
C0805732 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
C0205390 (UMLS CUI [2,1])
C2603343 (UMLS CUI [2,2])
C0011008 (UMLS CUI [3])
Item
Primary reason for withdrawal
integer
C0422727 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
Primary reason for withdrawal
Code List
Primary reason for withdrawal
CL Item
Adverse event (1)
CL Item
Lack of efficacy (2)
CL Item
Protocol deviation (3)
CL Item
Subject reached protocol-defined stopping criteria (4)
CL Item
Study closed/terminated (5)
CL Item
Lost to follow-up (6)
CL Item
Investigator discretion, specify (7)
CL Item
Withdrew consent, specify (8)
CL Item
Prohibited medication use  (029)
Specify Investigator discretion
Item
Specify Investigator discretion
text
C2348235 (UMLS CUI [1,1])
C0008961 (UMLS CUI [1,2])
C0022423 (UMLS CUI [1,3])
Specify withdrew consent
Item
Specify withdrew consent
text
C1707492 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial